We are pleased to announce that Profit Royal Pharmaceutical Limited is a supplier of China State Construction Engineering (Hong Kong) Limited (CSCE) (A member of China Overseas Holdings Ltd).To dedicate a comprehensive occupational safety and health protection among staffs, CSCE provides NASK Nanofibrous Masks for them to use at the construction sites.
We are pleased to announce that NASK has been shortlisted on the “2017 Hong Kong Emerging Brand Awards List”. For details please visit below link: http://www.hkbrand.org/en/event/3/page/3/brand/595?activePage=1&tab=114
The world celebrates World Intellectual Property Day (WIPD) on 26 April to honour the creators and innovators who enrich our world. NASK has been featured in both the South China Morning Post (SCMP) & Headline Newspaper (頭條日報) as one of the successful Innovation stories to come out of Hong Kong. Please click on the images below to[…]
NASK’s soon to be released PM2.5 ‘Sport Mask’ is being showcased at the 45th International Exhibition of Inventions – Geneva by the team at NAMI (Nano and Advanced Materials Institute Ltd) between 29 Mar – 2 Apr. Unlike N95 facemasks which can significantly decrease blood oxygen levels due to poor airflow – wearing the PM2.5[…]
The #Legislative Councillor for Information Technology – #Charles Mok Visited the #NASK Office with Sarinda Kwok and Stephen Kwok. The Parent company Profit Royal Pharmaceutical is the first Hong Kong based manufacturer to obtain NIOSH approval with performance verified by international NELSON LAB certification. CHARLES first looked at the Nanofiber-spinning machine to witness the first[…]
Profit Royal Pharmaceutical Limited is excited to announce our application for N95 approval has been granted by NIOSH U.S. Profit Royal Pharmaceutical Limited has made history by being the first and only company to manufacture a NIOSH N95 approved mask in Hong Kong under the NASK branding. NIOSH Is part of the U.S. Centers for Disease[…]
NASK Smart Mask was jointly developed by Profit Royal Pharmaceutical Limited (PR) and Nano and Advanced Material Institute (NAMI) in Hong Kong (ITC of the government of HKSAR has designated NAMI as the research centre for nanotechnology). On September 13, 2016 PR and North China Pharmaceutical Group (Tianjin) International Logistics Limited (NCPG) have entered into[…]